American Financial Network Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,464
Closed -$501K 100
2019
Q2
$501K Sell
7,464
-1,320
-15% -$86.8K 0.39% 70
2019
Q1
$565K Sell
8,784
-567
-6% -$37.7K 0.42% 67
2018
Q4
$585K Sell
9,351
-1,546
-14% -$108K 0.41% 75
2018
Q3
$841K Buy
10,897
+10,847
+21,694% +$819K 0.44% 68
2018
Q2
$788 Sell
50
-2
-4% -$141 0.43% 74
2018
Q1
$877 Sell
52
-15,289
-100% -$1.22M 0.46% 61
2017
Q4
$1.1M Sell
15,341
-2,835
-16% -$215K 0.46% 67
2017
Q3
$1.47M Buy
+18,176
New +$1.39M 0.63% 43

Other funds holding GILD

American Financial Network Advisory Services's GILD Position: Q3 2019 in Review

American Financial Network Advisory Services sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 7,464 shares — an estimated $501K sold.

American Financial Network Advisory Services first reported a position in GILD in Q3 2017 and held it in 8 quarters. The position peaked at $1.47M in Q3 2017. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • American Financial Network Advisory Services reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • American Financial Network Advisory Services sold 7,464 Gilead Sciences shares in Q3 2019, an estimated $501K.
  • American Financial Network Advisory Services first reported a position in Gilead Sciences in Q3 2017 and held it in 8 quarters.
  • American Financial Network Advisory Services's Gilead Sciences position peaked at $1.47M in Q3 2017.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on American Financial Network Advisory Services's 13F filing for Q3 2019, filed 12 Nov 2019.